Author Correction: The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy

被引：0
|
作者：
Yuichi Ikegami [1 ]
Ikuo Inoue [1 ]
Kaiji Inoue [2 ]
Yuichi Shinoda [3 ]
Shinichiro Iida [1 ]
Seiichi Goto [4 ]
Takanari Nakano [5 ]
Akira Shimada [1 ]
Mitsuhiko Noda [1 ]
机构：
[1] Saitama Medical University,Department of Endocrinology and Diabetology
[2] Saitama Medical University,Department of Radiology
[3] Ibaraki Rehabilitation Hospital,Department of Rehabilitation
[4] Saitama Medical University,Health Management Center
[5] Saitama Medical University,Department of Biochemistry
来源：
npj Aging | / 11卷 / 1期
关键词：
D O I：
10.1038/s41514-025-00208-1
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 29 条
  • [1] The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy
    Ikegami Y.
    Inoue I.
    Inoue K.
    Shinoda Y.
    Iida S.
    Goto S.
    Nakano T.
    Shimada A.
    Noda M.
    npj Aging and Mechanisms of Disease, 4 (1)
  • [2] A Case with Oligogenic Familial Hypercholesterolemia Treated by Combination Therapy of Statin, Ezetimibe, PCSK9 Inhibitor, and Lomitapide
    Kojima, Nobuko
    Tada, Hayato
    Takamura, Masayuki
    INTERNAL MEDICINE, 2025,
  • [3] PCSK9 Inhibitor with Statin Therapy for Intracranial Artery Stenosis ( PISTIAS): Rationale and design of a multicenter randomized controlled trial
    Hu, Xinzhi
    Zhang, Zongmuyu
    Liu, Caiyan
    Li, Mingli
    Liu, Yiyang
    Cheng, Anqi
    Yu, Qiuyu
    Guo, Haoyao
    Zou, Yinxi
    Zhou, Li
    Wang, Hebo
    Song, Bo
    You, Yong
    Xia, Jian
    Zhang, Jingfen
    Ai, Zhibing
    Sun, Qinjian
    Han, Ju
    Liu, Jing
    Lu, Baoquan
    Deng, Qiwen
    Li, Guanzeng
    Wang, Peng-fei
    Li, Xiangqing
    An, Yi
    Wu, Bo
    Yan, Zhongrui
    Wang, Yining
    Xu, Wei-Hai
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (09) : 1071 - 1076
  • [4] Cost-Effectiveness of PCSK9 Inhibitor Plus Statin in Patients With Triple-Vessel Coronary Artery Disease in Japan
    Kodera, Satoshi
    Morita, Hiroyuki
    Kiyosue, Arihiro
    Ando, Jiro
    Takura, Tomoyuki
    Komuro, Issei
    CIRCULATION JOURNAL, 2018, 82 (10) : 2602 - 2608
  • [5] Combination therapy of candesartan with statin inhibits progression of atherosclerosis more than statin alone in patients with coronary artery disease
    Suzuki, Takayuki
    Nozawa, Takashi
    Fujii, Nozomu
    Sobajima, Mitsuo
    Ohori, Takashi
    Shida, Takuya
    Matsuki, Akira
    Kameyama, Tomoki
    Inoue, Hiroshi
    CORONARY ARTERY DISEASE, 2011, 22 (05) : 352 - 358
  • [6] Use of PCSK9 Inhibitor Therapy in a Small Cohort of Heart Transplant Recipients with Statin Intolerance or Refractory Hyperlipidemia
    Jackson, R.
    Jennings, D.
    Gaine, M.
    Fanek, T.
    Mabasa, A.
    Lee, J.
    Kleet, A.
    Latif, F.
    Restaino, S.
    Farr, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S275 - S275
  • [7] Estimated individual lifetime benefit from PCSK9 inhibition in statin-treated patients with coronary artery disease
    Kaasenbrood, Lotte
    Ray, Kausik K.
    Boekholdt, S. Matthijs
    Smulders, Yvo M.
    LaRosa, John C.
    Kastelein, John J. P.
    van der Graaf, Yolanda
    Dorresteijn, Johannes A. N.
    Visseren, Frank L. J.
    HEART, 2018, 104 (20) : 1699 - 1705
  • [8] Effect of PCSK9 inhibition in combination with statin therapy on intracranial atherosclerotic stenosis: A high-resolution MRI study
    Wu, Lingshan
    Kong, Qianqian
    Huang, Hao
    Xu, Shabei
    Qu, Wensheng
    Zhang, Ping
    Yu, Zhiyuan
    Luo, Xiang
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [9] Circulating Mature Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Level Predicts Diminished Response to Statin Therapy in Patients With Coronary Artery Disease
    Naoto, Kuyama
    Yu, Kataoka
    Harada-Shiba, Mariko
    Hori, Mika
    Ogura, Masatsune
    Asaumi, Yasuhide
    Noguchi, Teruo
    Yasuda, Satoshi
    Kataoka, Yu
    CIRCULATION, 2019, 140
  • [10] PCSK9 and its relationship with HMGB1, TLR4, and TNFα in non-statin and statin-treated coronary artery disease patients
    Desouky, Dina A.
    Nosair, Nahla A.
    Salama, Mohamed K.
    El-Magd, Mohammed A.
    Desouky, Muhammad A.
    Sherif, Dalia E.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, : 2935 - 2949
123